55 related articles for article (PubMed ID: 2784652)
21. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.
Anderson PW; Pichichero ME; Insel RA; Betts R; Eby R; Smith DH
J Immunol; 1986 Aug; 137(4):1181-6. PubMed ID: 3016088
[TBL] [Abstract][Full Text] [Related]
22. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
Gordon LK
Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
[TBL] [Abstract][Full Text] [Related]
23. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine.
Rubin LG; Voulalas D; Carmody L
Pediatrics; 1989 Sep; 84(3):509-13. PubMed ID: 2788866
[TBL] [Abstract][Full Text] [Related]
24. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine.
Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L;
Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947
[TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity study of Haemophilus influenzae type B conjugate vaccine in Indian infants.
Phadke MA; Kulkarni MV; Sovani VB; Lokeshwar MR; Venkataraman R
Indian Pediatr; 1997 Sep; 34(9):779-83. PubMed ID: 9492415
[TBL] [Abstract][Full Text] [Related]
28. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide.
Lucas AH; Azmi FH; Mink CM; Granoff DM
J Immunol; 1993 Mar; 150(5):2056-61. PubMed ID: 8436834
[TBL] [Abstract][Full Text] [Related]
29. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.
Fernandez J; Levine OS; Sanchez J; Balter S; LaClaire L; Feris J; Romero-Steiner S
J Infect Dis; 2000 Nov; 182(5):1553-6. PubMed ID: 11023481
[TBL] [Abstract][Full Text] [Related]
30. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
[TBL] [Abstract][Full Text] [Related]
31. Effect of intravenous gammaglobulin therapy in IgG2 deficient and IgG2 sufficient children with recurrent infections and poor response to immunization with Hemophilus influenzae type b capsular polysaccharide antigen.
Silk HJ; Ambrosino D; Geha RS
Ann Allergy; 1990 Jan; 64(1):21-5. PubMed ID: 2297141
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age.
Greenberg DP; Ward JI; Burkart K; Christenson PD; Guravitz L; Marcy SM
Pediatr Infect Dis J; 1987 Jul; 6(7):660-5. PubMed ID: 3497380
[TBL] [Abstract][Full Text] [Related]
33. Capsular polysaccharide Haemophilus influenzae type b vaccine: clinical and immunologic responses to two vaccines.
Barkin RM; Hendley JO; Zahradnik J; McVerry P; Samuelson JS
Pediatr Infect Dis J; 1987 Jan; 6(1):20-3. PubMed ID: 3493475
[TBL] [Abstract][Full Text] [Related]
34. Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine.
Edwards KM; Decker MD; Palmer P; Porch CR; Sell SH; Wright PF
J Infect Dis; 1987 Feb; 155(2):283-91. PubMed ID: 3492571
[TBL] [Abstract][Full Text] [Related]
35. Antibody of polyribophate of Haemophilus influenzae type b in infants and children: effect of immunization with polyribophosphate.
Anderson P; Smith DH; Ingram DL; Wilkins J; Wehrle PF; Howie VM
J Infect Dis; 1977 Aug; 136 Suppl():S57-62. PubMed ID: 302291
[TBL] [Abstract][Full Text] [Related]
36. Subcutaneous versus intramuscular administration of Haemophilus influenzae type b vaccine.
Leung AK; Chiu AS; Siu TO
J R Soc Health; 1989 Apr; 109(2):71-3. PubMed ID: 2500525
[TBL] [Abstract][Full Text] [Related]
37. Use of the Haemophilus influenzae type b vaccine among preschool attendees.
Gilsdorf JR
Clin Pediatr (Phila); 1988 Jun; 27(6):285-8. PubMed ID: 3259486
[TBL] [Abstract][Full Text] [Related]
38. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule.
Pichichero ME; Insel RA
J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):481-6. PubMed ID: 6605372
[TBL] [Abstract][Full Text] [Related]
39. Hib vaccine efficacy trials continue; data needed about use in younger children.
Marwick C
JAMA; 1989 Apr; 261(14):2015, 2019. PubMed ID: 2648039
[No Abstract] [Full Text] [Related]
40. Clinical management of fever in children younger than three years of age.
Pusic MV
Paediatr Child Health; 2007 Jul; 12(6):469-472. PubMed ID: 19030410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
